BACKGROUND: This study aims to investigate potential markers of psoriasis and aging, and to elucidate possible connections between these two processes. METHODS: The serum samples of 60 psoriatic patients and 100 controls were analysed, and the levels of four selected parameters (AGEs, RAGE, NAD, and elastin) were determined using commercial ELISA kits. Serum C-reactive protein was assayed using an immune-nephelometry method. FINDINGS: Among the patients, the levels of CRP, AGEs, and RAGE were all increased, while the levels of NAD were reduced when compared to the control group. A negative correlation between the levels of AGEs and NAD was found. A negative correlation between age and the NAD levels among the control group was observed, however among the patients the relationship was diminished. While there was no difference in the levels of native elastin between the patients and the controls, a positive correlation between the levels of native elastin and age and a negative correlation between the levels of native elastin and the severity of psoriasis were found. CONCLUSIONS: The results of our study support the notion of psoriasis and possibly other immune-mediated diseases accelerating the aging process through sustained systemic damage. The serum levels of CRP, NAD, AGEs, and RAGE appear to be promising potential biomarkers of psoriasis. The decrease in the serum levels of NAD is associated with (pro)inflammatory states. Our analysis indicates that the levels of native elastin might strongly reflect both the severity of psoriasis and the aging process.

Clinic of Dermal and Venereal Diseases University Hospital 500 03 Hradec Kralove Czech Republic

Institute of Clinical Biochemistry and Diagnostics University Hospital Faculty of Medicine in Hradec Kralove Charles University 500 03 Hradec Kralove Czech Republic

Institute of Clinical Immunology and Allergology University Hospital Faculty of Medicine in Hradec Kralove Charles University 500 03 Hradec Kralove Czech Republic

Institute of Preventive Medicine Faculty of Medicine in Hradec Kralove Charles University 500 03 Hradec Kralove Czech Republic

Transfusion Center University Hospital 500 03 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Baker K.F., Isaacs J.D. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis? Ann. Rheum. Dis. 2018;77:175–187. doi: 10.1136/annrheumdis-2017-211555. PubMed DOI

Armstrong A.W., Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA—J. Am. Med. Assoc. 2020;323:1945–1960. doi: 10.1001/jama.2020.4006. PubMed DOI

Baş Y., Seçkin H.Y., Kalkan G., Takci Z., Çitil R., Önder Y., Şahin Ş., DEMİR A.K. Prevalence and related factors of psoriasis and seborrheic dermatitis: A communitybased study. Turk. J. Med. Sci. 2016;46:303–309. doi: 10.3906/sag-1406-51. PubMed DOI

Schonmann Y., Ashcroft D.M., Iskandar I.Y.K., Parisi R., Sde-Or S., Comaneshter D., Batat E., Shani M., Vinker S., Griffiths C.E., et al. Incidence and prevalence of psoriasis in Israel between 2011 and 2017. J. Eur. Acad. Dermatol. Venereol. 2019;33:2075–2081. doi: 10.1111/jdv.15762. PubMed DOI

Beranek M., Fiala Z., Kremlacek J., Andrys C., Krejsek J., Hamakova K., Chmelarova M., Palicka V., Borska L. Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis. Arch. Dermatol. Res. 2017;309:815–821. doi: 10.1007/s00403-017-1785-5. PubMed DOI

Cannavò S.P., Riso G., Casciaro M., Di Salvo E., Gangemi S. Oxidative stress involvement in psoriasis: A systematic review. Free Radic. Res. 2019;53:829–840. doi: 10.1080/10715762.2019.1648800. PubMed DOI

Biswas S.K. Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxid. Med. Cell. Longev. 2016;2016:5698931. doi: 10.1155/2016/5698931. PubMed DOI PMC

Borsky P., Chmelarova M., Fiala Z., Hamakova K., Palicka V., Krejsek J., Andrys C., Kremlacek J., Rehacek V., Beranek M., et al. Aging in psoriasis vulgaris: Female patients are epigenetically older than healthy controls. Immun. Ageing. 2021;18:10. doi: 10.1186/s12979-021-00220-5. PubMed DOI PMC

Holmannova D., Borsky P., Borska L., Andrys C., Hamakova K., Rehacek V., Svadlakova T., Malkova A., Beranek M., Palicka V., et al. Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris. Int. J. Mol. Sci. 2020;21:5617. doi: 10.3390/ijms21165617. PubMed DOI PMC

BBorska L., Kremlacek J., Andrys C., Krejsek J., Hamakova K., Borsky P., Palicka V., Rehacek V., Malkova A., Fiala Z. Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis. Int. J. Mol. Sci. 2017;18:2238. doi: 10.3390/ijms18112238. PubMed DOI PMC

Mehta N.N., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B., Gelfand J.M. Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the general practice research database. Eur. Heart J. 2010;31:1000–1006. doi: 10.1093/eurheartj/ehp567. PubMed DOI PMC

Howcroft T.K., Campisi J., Louis G.B., Smith M.T., Wise B., Wyss-Coray T., Augustine A.D., McElhaney J.E., Kohanski R., Sierra F. The role of inflammation in age-related disease. Aging. 2013;5:84–93. doi: 10.18632/aging.100531. PubMed DOI PMC

Chung H.Y., Ki W.C., Lee E.K., Chung K.W., Chung S., Lee B., Seo A.Y., Chung J.H., Jung Y.S., Im E., et al. Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept. Aging Dis. 2019;10:367–382. doi: 10.14336/AD.2018.0324. PubMed DOI PMC

SSingh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011;10:319–329. doi: 10.1016/j.arr.2010.11.002. PubMed DOI PMC

Covarrubias A.J., Perrone R., Grozio A., Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 2021;22:119–141. doi: 10.1038/s41580-020-00313-x. PubMed DOI PMC

Han G., Williams C.A., Salter K., Garl P.J., Li A.G., Wang X.-J. A Role for TGFβ Signaling in the Pathogenesis of Psoriasis. J. Investig. Dermatol. 2010;130:371–377. doi: 10.1038/jid.2009.252. PubMed DOI PMC

Krieglstein K., Miyazono K., Ten Dijke P., Unsicker K. TGF-β in aging and disease. Cell Tissue Res. 2012;347:5–9. doi: 10.1007/s00441-011-1278-3. PubMed DOI

Mezentsev A., Nikolaev A., Bruskin S. Matrix metalloproteinases and their role in psoriasis. Gene. 2014;540:1–10. doi: 10.1016/j.gene.2014.01.068. PubMed DOI

Hodges N.A., Suarez-Martinez A.D., Murfee W.L. Understanding angiogenesis during aging: Opportunities for discoveries and new models. J. Appl. Physiol. 2018;125:1843–1850. doi: 10.1152/japplphysiol.00112.2018. PubMed DOI PMC

Ahadi S., Zhou W., Rose S.M.S.-F., Sailani M.R., Contrepois K., Avina M., Ashland M., Brunet A., Snyder M. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat. Med. 2020;26:83–90. doi: 10.1038/s41591-019-0719-5. PubMed DOI PMC

Holmannova D., Borska L., Andrys C., Borsky P., Kremlacek J., Hamakova K., Rehacek V., Malkova A., Svadlakova T., Palicka V., et al. The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids. J. Immunol. Res. 2020;2020:7352637. doi: 10.1155/2020/7352637. PubMed DOI PMC

Rodríguez-Cerdeira C., Molares-Vila A., Sánchez-Blanco E., Sánchez-Blanco B. Study on Certain Biomarkers of Inflammation in Psoriasis Through “OMICS” Platforms. Open Biochem. J. 2014;8:21–34. doi: 10.2174/1874091X01408010021. PubMed DOI PMC

Lennarz W.J., Lane M.D. 2nd ed. Academic Press; Cambridge, MA, USA: 2013. Encyclopedia of Biological Chemistry.

Yan S.F., Ramasamy R., Naka Y., Schmidt A.M. Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond. Circ. Res. 2003;93:1159–1169. doi: 10.1161/01.RES.0000103862.26506.3D. PubMed DOI

Papagrigoraki A., Maurelli M., Del Giglio M., Gisondi P., Girolomoni G. Advanced glycation end products in the pathogenesis of psoriasis. Int. J. Mol. Sci. 2017;18:2471. doi: 10.3390/ijms18112471. PubMed DOI PMC

Palanissami G., Paul S.F.D. RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—A Review. Horm. Cancer. 2018;9:295–325. doi: 10.1007/s12672-018-0342-9. PubMed DOI PMC

Parks W.C., Pierce R.A., Lee K.A., Mecham R.P. Elastin. Adv. Mol. Cell Biol. 1993;6:133–181. doi: 10.1016/S1569-2558(08)60201-5. DOI

Heinz A. Elastases and elastokines: Elastin degradation and its significance in health and disease. Crit. Rev. Biochem. Mol. Biol. 2020;55:252–273. doi: 10.1080/10409238.2020.1768208. PubMed DOI

Scandolera A., Odoul L., Salesse S., Guillot A., Blaise S., Kawecki C., Maurice P., El Btaouri H., Romier-Crouzet B., Martiny L., et al. The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral Potential. Front. Pharmacol. 2016;7:32. doi: 10.3389/fphar.2016.00032. PubMed DOI PMC

Antonicelli F., Bellon G., Debelle L., Hornebeck W. Elastin-Elastases and Inflamm-Aging. Curr. Top. Dev. Biol. 2007;79:99–155. doi: 10.1016/S0070-2153(06)79005-6. PubMed DOI

Kucich U., Rosenbloom J.C., Abrams W.R., Bashir M., Rosenbloom J. Stabilization of elastin mRNA by TGF-β: Initial characterization of signaling pathway. Pneumologie. 1997;51:1080. doi: 10.1165/ajrcmb.17.1.2816. PubMed DOI

Colburn K.K., Kelly G.T., Malto M.C., Sandberg L.B., Boucek R.J. Serum anti-tropo: Anti-alpha-elastin antibody ratio assessing elastin turnover in scleroderma. Clin. Rheumatol. 1992;11:206–210. doi: 10.1007/BF02207958. PubMed DOI

Krettek A., Sukhova G.K., Libby P. Elastogenesis in human arterial disease: A role for macrophages in disordered elastin synthesis. Arterioscler Thromb. Vasc. Biol. 2003;23:582–587. doi: 10.1161/01.ATV.0000064372.78561.A5. PubMed DOI

Ungerstedt J.S., Blombäck M., Söderström T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin. Exp. Immunol. 2003;131:48–52. doi: 10.1046/j.1365-2249.2003.02031.x. PubMed DOI PMC

Radenkovic D., Verdin E. Clinical evidence for targeting nad therapeutically. Pharmaceuticals. 2020;13:247. doi: 10.3390/ph13090247. PubMed DOI PMC

Namazi M.R. Nicotinamide: A potential addition to the anti-psoriatic weaponry. FASEB J. 2003;17:1377–1379. doi: 10.1096/fj.03-0002hyp. PubMed DOI

Gustafson C.J., Watkins C., Hix E., Feldman S.R. Combination therapy in psoriasis: An evidence-based review. Am. J. Clin. Dermatol. 2013;14:9–25. doi: 10.1007/s40257-012-0003-7. PubMed DOI

Rinnerthaler M., Streubel M.K., Bischof J., Richter K. Skin aging, gene expression and calcium. Exp. Gerontol. 2015;68:59–65. doi: 10.1016/j.exger.2014.09.015. PubMed DOI

Boehncke W.H., Schön M.P. Psoriasis. Lancet. 2015;386:983–994. doi: 10.1016/S0140-6736(14)61909-7. PubMed DOI

Beygi S., Lajevardi V., Abedini R. C-reactive protein in psoriasis: A review of the literature. J. Eur. Acad. Dermatol. Venereol. 2014;28:700–711. doi: 10.1111/jdv.12257. PubMed DOI

Okan G., Baki A.M., Yorulmaz E., Dogru-Abbasoglu S., Vural P. Fibroblast growth factor 23 and placental growth factor in patients with psoriasis and their relation to disease severity. Ann. Clin. Lab. Sci. 2016;46:174–179. PubMed

Choi J., Joseph L., Pilote L. Obesity and C-reactive protein in various populations: A systematic review and meta-analysis. Obes. Rev. 2013;14:232–244. doi: 10.1111/obr.12003. PubMed DOI

Oikarinen A., Tamminen M., Karvonen J., Reunala T., Kallioinen M., Hannuksela M., Ala-Kokko L. Effect of long-term PUVA treatment of psoriasis on the collagen and elastin gene expression and growth of skin fibroblasts in vitro. Br. J. Dermatol. 1990;123:621–630. doi: 10.1111/j.1365-2133.1990.tb01479.x. PubMed DOI

Mora Huertas A.C., Schmelzer C.E.H., Hoehenwarter W., Heyroth F., Heinz A. Molecular-level insights into aging processes of skin elastin. Biochimie. 2016;128–129:163–173. doi: 10.1016/j.biochi.2016.08.010. PubMed DOI

Nackman G.B., Karkowski F.J., Halpern V.J., Gaetz H.P., Tilson M.D. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery. 1997;122:39–44. doi: 10.1016/S0039-6060(97)90262-2. PubMed DOI

Chua R.A., Arbiser J.L. The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity. 2009;42:574–579. doi: 10.1080/08916930903002461. PubMed DOI

Socha M., Kicinski P., Feldo M., Zubilewicz T., Pietrzak A. Assessment of selected angiogenesis markers in the serum of middle-aged male patients with plaque psoriasis. Dermatol. Ther. 2021;34:e14727. doi: 10.1111/dth.14727. PubMed DOI

Van Lammeren G.W., Moll F.L., De Borst G.J., De Kleijn D.P., De Vries J.-P.P., Pasterkamp G. Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque. Curr. Cardiol. Rev. 2011;7:22–27. doi: 10.2174/157340311795677680. PubMed DOI PMC

Nockowski P., Szepietowski J.C., Ziarkiewicz M., Baran E. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris. Acta Dermatovenerol. Croat. 2004;12:2–6. PubMed

Flisiak I., Zaniewski P., Chodynicka B. Plasma TGF-β1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity. Biomarkers. 2008;13:549–556. doi: 10.1080/13547500802033300. PubMed DOI

Nallasamy S., Yoshida K., Akins M., Myers K., Iozzo R., Mahendroo M. Steroid Hormones Are Key Modulators of Tissue Mechanical Function via Regulation of Collagen and Elastic Fibers. Endocrinology. 2017;158:950–962. doi: 10.1210/en.2016-1930. PubMed DOI PMC

Lephart E.D., Naftolin F. Menopause and the Skin: Old Favorites and New Innovations in Cosmeceuticals for Estrogen-Deficient Skin. Dermatol. Ther. 2020;11:53–69. doi: 10.1007/s13555-020-00468-7. PubMed DOI PMC

Clarke R.E., Dordevic A.L., Tan S.M., Ryan L., Coughlan M.T. Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials. Nutrients. 2016;8:125. doi: 10.3390/nu8030125. PubMed DOI PMC

Ramasamy R., Yan S.F., Schmidt A.M. RAGE: Therapeutic target and biomarker of the inflammatory response-the evidence mounts. J. Leukoc. Biol. 2009;86:505–512. doi: 10.1189/jlb.0409230. PubMed DOI

Papagrigoraki A., Del Giglio M., Cosma C., Maurelli M., Girolomoni G., Lapolla A. Advanced glycation end products are increased in the skin and blood of patients with severe psoriasis. Acta Derm. Venereol. 2017;97:782–787. doi: 10.2340/00015555-2661. PubMed DOI

Jaisson S., Gillery P. Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteins. Clin. Chem. 2010;56:1401–1412. doi: 10.1373/clinchem.2010.145201. PubMed DOI

Mezentsev A.V., Bruskin S.A., Soboleva A.G., Sobolev V.V., Piruzian E.S. Pharmacological control of receptor of ddvanced glycation end-products and its biological effects in psoriasis. Int. J. Biomed. Sci. 2013;9:112–122. PubMed PMC

Sparvero L.J., Asafu-Adjei D., Kang R., Tang D., Amin N., Im J., Rutledge R., Lin B., Amoscato A.A., Zeh H.J., et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation. J. Transl. Med. 2009;7:17. doi: 10.1186/1479-5876-7-17. PubMed DOI PMC

Yaku K., Okabe K., Nakagawa T. NAD metabolism: Implications in aging and longevity. Ageing Res. Rev. 2018;47:1–17. doi: 10.1016/j.arr.2018.05.006. PubMed DOI

Li L., Renier G. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. Metabolism. 2006;55:1516–1523. doi: 10.1016/j.metabol.2006.06.022. PubMed DOI

Shi X.Y., Hou F.F., Niu H.X., Wang G.B., Xie D., Guo Z.J., Zhou Z.M., Yang F., Tian J.W., Zhang X. Advanced Oxidation Protein Products Promote Inflammation in Diabetic Kidney through Activation of Renal Nicotinamide Adenine Dinucleotide Phosphate Oxidase. Endocrinology. 2008;149:1829–1839. doi: 10.1210/en.2007-1544. PubMed DOI

Evaluation of potential aging biomarkers in healthy individuals: telomerase, AGEs, GDF11/15, sirtuin 1, NAD+, NLRP3, DNA/RNA damage, and klotho

Non-Genomic Hallmarks of Aging-The Review

Chromosomal Aberrations and Oxidative Stress in Psoriatic Patients with and without Metabolic Syndrome